Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V. | Chief Scientific Officer, Director | Ordinary Shares | 0 | $0 | $21.50 | Mar 26, 2024 | Indirect |
NewAmsterdam Pharma Co N.V. | Chief Scientific Officer, Director | Option (right to buy) | 970K | Mar 26, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Mar 26, 2024 | 4 | -$4.35M | 4 | Mar 27, 2024 | Chief Scientific Officer, Director |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Chief Scientific Officer, Director |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Chief Scientific Officer, Director |